Clinical Trial Update: Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing deferiprone to deferasirox in pediatric patients with chronic iron overload has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)
• Deferiprone (deferiprone)

Snippet

Sponsor: Consorzio per Valutazioni Biologiche e Farmacologiche | Conditions: Chronic Iron Overload | Phase 3 | Status: COMPLETED | Results posted: 2021-04-08